The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Adult Neurogenesis in Neurodegenerative Diseases: Figure 1.
Open accessAbstract
Adult neurogenesis is limited to specific brain regions in the mammalian brain, such as the hippocampal dentate gyrus and the subventricular zone/olfactory bulb system.Alterations in adult neurogenesis appear to be a common hallmark in different neurodegenerative diseases including Parkinson's disease (PD), Alzheimer's disease (AD), and Huntington's disease (HD).This is remarkable, because the distinct pathological proteins responsible for the different diseases induce the loss of different neural populations.Impaired adult neurogenesis was shown in numerous animal models of neurodegenerative diseases; however, only few postmortem studies have been performed.We will review concepts related to the interplay between cellular plasticity in regions of adult neurogenesis with a specific focus on cellautonomous and non-cell-autonomous factors.Furthermore, various strategies aimed to stimulate neuronal plasticity will be discussed within the context of a potential translation into therapeutic approaches for neuropsychiatric symptoms associated with PD, HD, and AD. REGULATION OF NEUROGENESIS IN THE ADULT BRAINA ltman and colleagues were the first scientists to report adult neurogenesis (Altman and Das 1965; Altman 1969), and this observation changed the dogma that the mammalian brain is incapable of generating new neurons.New neurons generated throughout life are one component of brain plasticity-a cellular processhowever, limited to distinct brain regions harboring adult neural stem and precursor cells, primarily the subventricular zone (SVZ) adjacent to the lateral ventricles and the subgranular zone (SGZ) of the dentate gyrus (DG) of the hippocampus.As described in detail elsewhere in the literature, adult neurogenesis involves several crucial steps of neural development.An important aspect regarding adult neurogenesis is its modulation as a result of a variety of genetic, epigenetic, and transcriptional factors as well as environmental factors, age, and acute and chronic diseases (Ma et al. 2010;Mu et al. 2010).At this point, one may ask: Why is the generation of new neurons in distinct regions of the brain important for neurodegenerative diseases?Gradual loss of different neuronal populations occurs in monogenic and sporadic neurodegenerative diseases.Diseased neurons have
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Masliah, E., Rockenstein, E., Mante, M., Crews, L., Spencer, B., Adame, A., Patrick, C., Trejo, M., Ubhi, K., Rohn, T. T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019338 · Cited by 423
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110 · cited 1×
“PD is the most common movement disorder with an increasing prevalence because of an aging population (de Lau and Breteler 2006).”
BackgroundAlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats
Altman, J., & Das, G. D. (1965) · Journal of Comparative Neurology · doi:10.1002/cne.901240303 · Cited by 3,592
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Functional neurogenesis in the adult hippocampus
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., & Gage, F. H. (2002) · Nature · doi:10.1038/4151030a · Cited by 2,853
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Walker, F. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60111-1 · Cited by 2,603
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,246
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Dynamics of hippocampal neurogenesis in adult humans
Spalding, K. L., Bergmann, O., Alkass, K., Bernard, S., Salehpour, M., Huttner, H. B., Boström, E., Westerlund, I., Vial, C., Buchholz, B. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.002 · Cited by 1,841
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722
Altman, J. (1969) · Journal of Comparative Neurology · doi:10.1002/cne.901370404 · Cited by 1,489
Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316
Grazia Spillantini, M., Anthony Crowther, R., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,025
Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex
De Strooper, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00205-8 · Cited by 965
Dopamine depletion impairs precursor cell proliferation in Parkinson disease
Höglinger, G. U., Rizk, P., Muriel, M. P., Duyckaerts, C., Oertel, W. H., Caille, I., & Hirsch, E. C. (2004) · Nature Neuroscience · doi:10.1038/nn1265 · Cited by 944
Neurogenesis in the striatum of the adult human brain
Ernst, A., Alkass, K., Bernard, S., Salehpour, M., Perl, S., Tisdale, J., Possnert, G., Druid, H., & Frisén, J. (2014) · Cell · doi:10.1016/j.cell.2014.01.044 · Cited by 937
The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
Selkoe, D. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01363-4 · Cited by 862
AXON RETRACTION AND DEGENERATION IN DEVELOPMENT AND DISEASE
Luo, L., & O'Leary, D. D. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135632 · Cited by 844
Hodgson, J. G., Agopyan, N., Gutekunst, C.-A., Leavitt, B. R., LePiane, F., Singaraja, R., Smith, D. J., Bissada, N., McCutcheon, K., Nasir, J., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80764-3 · Cited by 830
Genetic Animal Models of Parkinson's Disease
Dawson, T. M., Ko, H. S., & Dawson, V. L. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.034 · Cited by 823
Antidepressants increase neural progenitor cells in the human hippocampus
Boldrini, M., Underwood, M. D., Hen, R., Rosoklija, G. B., Dwork, A. J., John Mann, J., & Arango, V. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.75 · Cited by 686
Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
Appel‐Cresswell, S., Vilarino‐Guell, C., Encarnacion, M., Sherman, H., Yu, I., Shah, B., Weir, D., Thompson, C., Szu‐Tu, C., Trinh, J., et al. (2013) · Movement Disorders · doi:10.1002/mds.25421 · Cited by 667
DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease
Yang, Y., Geldmacher, D. S., & Herrup, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02661.2001 · Cited by 616
Gray, M., Shirasaki, D. I., Cepeda, C., Andre, V. M., Wilburn, B., Lu, X.-H., Tao, J., Yamazaki, I., Li, S.-H., Sun, Y. E., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0857-08.2008 · Cited by 613
The incidence and prevalence of Huntington's disease: A systematic review and meta‐analysis
Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., & Jette, N. (2012) · Movement Disorders · doi:10.1002/mds.25075 · Cited by 587
The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology
MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K., & Abeliovich, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.008 · Cited by 564
Neuropsychiatric symptoms in Parkinson's disease
Aarsland, D., Marsh, L., & Schrag, A. (2009) · Movement Disorders · doi:10.1002/mds.22589 · Cited by 557
Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain
Curtis, M. A., Penney, E. B., Pearson, A. G., van Roon-Mom, W. M. C., Butterworth, N. J., Dragunow, M., Connor, B., & Faull, R. L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1532244100 · Cited by 523
Delaying the onset of Huntington's in mice
van Dellen, A., Blakemore, C., Deacon, R., York, D., & Hannan, A. J. (2000) · Nature · doi:10.1038/35008142 · Cited by 511
Gallagher, D. A., Lees, A. J., & Schrag, A. (2010) · Movement Disorders · doi:10.1002/mds.23394 · Cited by 509
Haughey, N. J., Nath, A., Chan, S. L., Borchard, A. C., Rao, M. S., & Mattson, M. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01267.x · Cited by 466
Double-knockout mice for α- and β-synucleins: Effect on synaptic functions
Chandra, S., Fornai, F., Kwon, H.-B., Yazdani, U., Atasoy, D., Liu, X., Hammer, R. E., Battaglia, G., German, D. C., Castillo, P. E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406283101 · Cited by 438
Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APP Sw,Ind ) mice
Jin, K., Galvan, V., Xie, L., Mao, X. O., Gorostiza, O. F., Bredesen, D. E., & Greenberg, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403678101 · Cited by 436
Neurodegenerative disease and adult neurogenesis
Winner, B., Kohl, Z., & Gage, F. H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07613.x · Cited by 405
Self-citationNeurocognitive signs in prodromal Huntington disease.
Stout, J. C., The PREDICT-HD Investigators and Coordinators of the Huntington Study Group, Paulsen, J. S., Queller, S., Solomon, A. C., Whitlock, K. B., Campbell, J. C., Carlozzi, N., Duff, K., Beglinger, L. J., et al. (2011) · Neuropsychology · doi:10.1037/a0020937 · Cited by 384
Rodríguez, J. J., Jones, V. C., Tabuchi, M., Allan, S. M., Knight, E. M., LaFerla, F. M., Oddo, S., & Verkhratsky, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002935 · Cited by 377
Signaling in Adult Neurogenesis
Suh, H., Deng, W., & Gage, F. H. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113256 · Cited by 375
Spires, T. L., Grote, H. E., Varshney, N. K., Cordery, P. M., van Dellen, A., Blakemore, C., & Hannan, A. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1658-03.2004 · Cited by 365
Transgenic rat model of Huntington's disease
von Horsten, S. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.6.617 · Cited by 359
Long-term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson Disease
Hauser, R. A., Freeman, T. B., Snow, B. J., Nauert, M., Gauger, L., Kordower, J. H., & Olanow, C. W. (1999) · Archives of Neurology · doi:10.1001/archneur.56.2.179 · Cited by 353
Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease
Donovan, M. H., Yazdani, U., Norris, R. D., Games, D., German, D. C., & Eisch, A. J. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20840 · Cited by 351
Boldrini, M., Hen, R., Underwood, M. D., Rosoklija, G. B., Dwork, A. J., Mann, J. J., & Arango, V. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.024 · Cited by 348
Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction
Pavese, N., Metta, V., Bose, S. K., Chaudhuri, K. R., & Brooks, D. J. (2010) · Brain · doi:10.1093/brain/awq268 · Cited by 333
Epigenetic choreographers of neurogenesis in the adult mammalian brain
Ma, D. K., Marchetto, M. C., Guo, J. U., Ming, G.-L., Gage, F. H., & Song, H. (2010) · Nature Neuroscience · doi:10.1038/nn.2672 · Cited by 331
Neurogenesis and Alzheimer's disease: At the crossroads
Lazarov, O., & Marr, R. A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.009 · Cited by 327
Boekhoorn, K., Joels, M., & Lucassen, P. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.017 · Cited by 325
Scalzo, P., Kümmer, A., Bretas, T. L., Cardoso, F., & Teixeira, A. L. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5357-2 · Cited by 299
Li, G., Bien-Ly, N., Andrews-Zwilling, Y., Xu, Q., Bernardo, A., Ring, K., Halabisky, B., Deng, C., Mahley, R. W., & Huang, Y. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.10.015 · Cited by 288
Melrose, H. L., Dächsel, J. C., Behrouz, B., Lincoln, S. J., Yue, M., Hinkle, K. M., Kent, C. B., Korvatska, E., Taylor, J. P., Witten, L., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.07.010 · Cited by 275
Pang, T. Y. C., Stam, N. C., Nithianantharajah, J., Howard, M. L., & Hannan, A. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.04.013 · Cited by 265
Diagnosis and the premotor phase of Parkinson disease
Tolosa, E., Gaig, C., Santamaría, J., & Compta, Y. (2009) · Neurology · doi:10.1212/wnl.0b013e318198db11 · Cited by 255
Mochel, F., Charles, P., Seguin, F., Barritault, J., Coussieu, C., Perin, L., Le Bouc, Y., Gervais, C., Carcelain, G., Vassault, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000647 · Cited by 238
Nonmotor manifestations of Parkinson's disease
Simuni, T., & Sethi, K. (2009) · Annals of Neurology · doi:10.1002/ana.21472 · Cited by 235
Bossers, K., Wirz, K. T. S., Meerhoff, G. F., Essing, A. H. W., van Dongen, J. W., Houba, P., Kruse, C. G., Verhaagen, J., & Swaab, D. F. (2010) · Brain · doi:10.1093/brain/awq258 · Cited by 230
Walker, F. (2007) · Seminars in Neurology · doi:10.1055/s-2007-971176 · Cited by 229
Crews, L., Adame, A., Patrick, C., DeLaney, A., Pham, E., Rockenstein, E., Hansen, L., & Masliah, E. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1305-10.2010 · Cited by 222
Zhang, C., McNeil, E., Dressler, L., & Siman, R. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.09.018 · Cited by 217
Neurodegeneration Across Stages of Cognitive Decline in Parkinson Disease
Weintraub, D. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.725 · Cited by 217
Signaling in adult neurogenesis
Mu, Y., Lee, S. W., & Gage, F. H. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.04.010 · Cited by 215
The Non-Amyloidogenic Pathway: Structure and Function of α-Secretases
Kojro, E., & Fahrenholz, F. (2006) · Subcellular Biochemistry · doi:10.1007/0-387-23226-5_5 · Cited by 213
Lucassen, P. J., Stumpel, M. W., Wang, Q., & Aronica, E. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.01.012 · Cited by 212
Mirochnic, S., Wolf, S., Staufenbiel, M., & Kempermann, G. (2009) · Hippocampus · doi:10.1002/hipo.20560 · Cited by 208
O'Keeffe, G. C., Tyers, P., Aarsland, D., Dalley, J. W., Barker, R. A., & Caldwell, M. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803955106 · Cited by 208
Sun, B., Halabisky, B., Zhou, Y., Palop, J. J., Yu, G., Mucke, L., & Gan, L. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.10.003 · Cited by 205
Miller, J. P., Holcomb, J., Al-Ramahi, I., de Haro, M., Gafni, J., Zhang, N., Kim, E., Sanhueza, M., Torcassi, C., Kwak, S., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.06.021 · Cited by 186
Neurodegeneration and Motor Dysfunction in a Conditional Model of Parkinson's Disease
Nuber, S., Petrasch-Parwez, E., Winner, B., Winkler, J., von Hörsten, S., Schmidt, T., Boy, J., Kuhn, M., Nguyen, H. P., Teismann, P., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3040-07.2008 · Cited by 176
Self-citationLazic, S. E., Grote, H. E., Blakemore, C., Hannan, A. J., van Dellen, A., Phillips, W., & Barker, R. A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04715.x · Cited by 173
Peng, Q., Masuda, N., Jiang, M., Li, Q., Zhao, M., Ross, C. A., & Duan, W. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.015 · Cited by 173
Choi, S. H., Veeraraghavalu, K., Lazarov, O., Marler, S., Ransohoff, R. M., Ramirez, J. M., & Sisodia, S. S. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.033 · Cited by 170
Sathasivam, K., Lane, A., Legleiter, J., Warley, A., Woodman, B., Finkbeiner, S., Paganetti, P., Muchowski, P. J., Wilson, S., & Bates, G. P. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp467 · Cited by 167
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice
Gil, J. M. A. C., Mohapel, P., Araújo, I. M., Popovic, N., Li, J.-Y., Brundin, P., & Petersén, Å. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.006 · Cited by 167
Adult neurogenesis in Parkinson’s disease
Marxreiter, F., Regensburger, M., & Winkler, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1062-x · Cited by 165
Self-citationHuman Wild-Type α-Synuclein Impairs Neurogenesis
Winner, B., Lie, D. C., Rockenstein, E. M., Aigner, R., Aigner, L., Masliah, E., Kuhn, H. G., & Winkler, J. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.11.1155 · Cited by 156
Self-citationDecreased hippocampal cell proliferation in R6/1 Huntington’s mice
Lazic, S. E., Grote, H., Armstrong, R. J. E., Blakemore, C. B., Hannan, A. J., van Dellen, A., & Barker, R. A. (2004) · Neuroreport · doi:10.1097/00001756-200404090-00014 · Cited by 155
Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease?
Hinnell, C., Hurt, C. S., Landau, S., Brown, R. G., Samuel, M., & on behalf of the PROMS‐PD Study Group (2012) · Movement Disorders · doi:10.1002/mds.23961 · Cited by 142
Cho, S., Benraiss, A., Chmielnicki, E., Samdani, A. F., Economides, A. N., & Goldman, S. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31778 · Cited by 141
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Redmond, D. E., Sladek, J. R., & Spencer, D. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107123450214 · Cited by 135
Curtis, M. A., Penney, E. B., Pearson, J. F., Dragunow, M., Connor, B. J., & Faull, R. L. M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.051 · Cited by 134
Crews, L. A., Mizuno, H., Desplats, P., Rockenstein, E. M., Adame, A., Patrick, C., Winner, B., Winkler, J., & Masliah, E. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0066-08.2008 · Cited by 134
Self-citationHippocampal abnormalities and memory deficits in Parkinson disease: A multimodal imaging study
Carlesimo, G. A., Piras, F., Assogna, F., Pontieri, F. E., Caltagirone, C., & Spalletta, G. (2012) · Neurology · doi:10.1212/wnl.0b013e318259e1c5 · Cited by 130
Phillips, W., Morton, A. J., & Barker, R. A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3796-05.2005 · Cited by 129
Role of α-Synuclein in Adult Neurogenesis and Neuronal Maturation in the Dentate Gyrus
Winner, B., Regensburger, M., Schreglmann, S. R., Boyer, L. F., Prots, I., Rockenstein, E. M., Mante, M., Zhao, C., Winkler, J., Masliah, E., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2723-12.2012 · Cited by 124
Self-citationThe proliferative capacity of the subventricular zone is maintained in the parkinsonian brain
van den Berge, S. A., van Strien, M. E., Korecka, J. A., Dijkstra, A. A., Sluijs, J. A., Kooijman, L., Eggers, R., Filippis, L. D., Vescovi, A. L., Verhaagen, J., et al. (2011) · Brain · doi:10.1093/brain/awr256 · Cited by 123
Varvel, N. H., Bhaskar, K., Kounnas, M. Z., Wagner, S. L., Yang, Y., Lamb, B. T., & Herrup, K. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39716 · Cited by 122
Huntington and its Role in Neuronal Degeneration
Li, S., & Li, X. (2004) · The Neuroscientist · doi:10.1177/1073858404266777 · Cited by 115
Epidemiology of Parkinson's disease
Liu, S., & Chan, P. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.3969/cjcnn.v16i2.1351 · Cited by 115
Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease
Simpson, J. M., Gil‐Mohapel, J., Pouladi, M. A., Ghilan, M., Xie, Y., Hayden, M. R., & Christie, B. R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.012 · Cited by 114
Crews, L. A., Rockenstein, E. M., & Masliah, E. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0232-6 · Cited by 112
Melrose, H. L., Kent, C., Taylor, J. P., Dächsel, J. C., Hinkle, K. M., Lincoln, S. J., Mok, S. S., Culvenor, J. G., Masters, C. L., Tyndall, G., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.05.027 · Cited by 109
Transgenic Models of α‐Synuclein Pathology: Past, Present, and Future
Hashimoto, M., Rockenstein, E. M., & Masliah, E. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07475.x · Cited by 108
Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model
Kohl, Z., Winner, B., Ubhi, K., Rockenstein, E., Mante, M., Münch, M., Barlow, C., Carter, T., Masliah, E., & Winkler, J. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07933.x · Cited by 101
Self-citationKandasamy, M., Couillard‐Després, S., Raber, K. A., Stephan, M., Lehner, B., Winner, B., Kohl, Z., Rivera, F. J., Nguyen, H. P., Rieß, O., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181e4f733 · Cited by 96
Self-citationEpidemiology of Parkinson’s Disease
Khandhar, S. M., & Marks, W. J. (2007) · Disease-a-Month · doi:10.1016/j.disamonth.2007.02.001 · Cited by 94
Neurogenesis and Alzheimers Disease: Biology and Pathophysiology in Mice and Men
Marlatt, M. W., & Lucassen, P. J. (2010) · Current Alzheimer Research · doi:10.2174/156720510790691362 · Cited by 91
Kohl, Z., Kandasamy, M., Winner, B., Aigner, R., Groß, C., Couillard‐Després, S., Bogdahn, U., Aigner, L., & Winkler, J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.039 · Cited by 87
Self-citationOrvoën, S., Pla, P., Gardier, A. M., Saudou, F., & David, D. J. P. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.11.063 · Cited by 75
Review: The future of cell therapies and brain repair: P arkinson's disease leads the way
Petit, G. H., Olsson, T. T., & Brundin, P. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12110 · Cited by 74
Impaired adult olfactory bulb neurogenesis in the R6/2 mouse model of Huntington's disease
Kohl, Z., Regensburger, M., Aigner, R., Kandasamy, M., Winner, B., Aigner, L., & Winkler, J. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-114 · Cited by 74
Self-citationAsialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice
Gil‐Mohapel, J., Leist, M., Popović, N., Brundin, P., & Petersén, Å. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-17 · Cited by 69
ROCKENSTEIN, E., CREWS, L., & MASLIAH, E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.013 · Cited by 65
Neurogenesis in the R6/2 mouse model of Huntington's disease is impaired at the level of NeuroD1
Fedele, V., Roybon, L., Nordström, U., Li, J., & Brundin, P. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.022 · Cited by 60
Presenilin mouse and zebrafish models for dementia: Focus on neurogenesis
van Tijn, P., Kamphuis, W., Marlatt, M. W., Hol, E. M., & Lucassen, P. J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.10.008 · Cited by 43
Benn, C., Luthi‐Carter, R., Kuhn, A., Sadri‐Vakili, G., Blankson, K. L., Dalai, S. C., Goldstein, D. R., Spires‐Jones, T. L., Pritchard, J. I., Olson, J. M., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ea167f · Cited by 37
No change in progenitor cell proliferation in the hippocampus in Huntington's disease
Low, V. F., Dragunow, M., Tippett, L. J., Faull, R. L. M., & Curtis, M. A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.010 · Cited by 36
Enhanced dendritogenesis and axogenesis in hippocampal neuroblasts of LRRK2 knockout mice
Paus, M., Kohl, Z., Abdallah, N. M. ‐. B., Galter, D., Gillardon, F., & Winkler, J. (2012) · Brain Research · doi:10.1016/j.brainres.2012.12.024 · Cited by 32
Self-citationAdult Neurogenesis Is Altered by GABAergic Imbalance in Models of Alzheimer's Disease
Schinder, A. F., & Morgenstern, N. A. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.11.007 · Cited by 10
Cited by
Adult Neurogenesis in the Hippocampus: From Stem Cells to Behavior
Gonçalves, J. T., Schafer, S. T., & Gage, F. H. (2016) · Cell · doi:10.1016/j.cell.2016.10.021 · Cited by 1,122
microRNA dysregulation in neurodegenerative diseases: A systematic review
Juźwik, C. A., S. Drake, S., Zhang, Y., Paradis-Isler, N., Sylvester, A., Amar-Zifkin, A., Douglas, C., Morquette, B., Moore, C. S., & Fournier, A. E. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101664 · Cited by 426
Numakawa, T., Odaka, H., & Adachi, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113650 · Cited by 353
Nutritional Factors Affecting Adult Neurogenesis and Cognitive Function
Poulose, S. M., Miller, M. G., Scott, T., & Shukitt-Hale, B. (2017) · Advances in Nutrition · doi:10.3945/an.117.016261 · Cited by 265
Adult neurogenesis and neurodegenerative diseases: A systems biology perspective
Horgusluoglu, E., Nudelman, K., Nho, K., & Saykin, A. J. (2017) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32429 · Cited by 174
Metadata
- Authors
- Winner, B., & Winkler, J.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2015-04
- Volume
- 7
- Issue
- 4
- Pages
- a021287
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2102799749
- Cited by
- 305
- References
- 118
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.